MedPath

Biomechanics Based Prediction of Preterm Delivery

Completed
Conditions
Preterm Delivery
Registration Number
NCT02037334
Lead Sponsor
David Scheiner
Brief Summary

Quantitative information on the biomechanical properties of the ecto-cervix in mid-pregnancy will be compared between women with term vs. preterm delivery. We aim to demonstrate that biomechanical data (ASP and CCI) might complement morphological data (CL) to improve prediction of preterm delivery. It is expected that women with preterm delivery will show stronger weakening of cervical tissue. Aspiration (ASP) and cervical CCI (cervical consistency index) measurements are performed at mid-pregnancy: detection at this time point is useful for therapy and biomechanical modifications are already significant so to enable differentiation by biomechanical measurements (ASP and CCI).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
1002
Inclusion Criteria
  • All pregnant women presenting at their mid pregnancy consultation (18+0 - 22+0 weeks of pregnancy) are eligible
  • Signed informed consent after being informed is a prerequisite for enrollment.
Exclusion Criteria
  • Communication problems
  • Missing consent
  • Age<18
  • Active bleeding / Premature Rupture of Membranes (PROM)
  • Active genital infection
  • Known carrier of HIV or Hepatitis B or C
  • Placenta praevia
  • Müllerian anomalies
  • known or suspected non-compliance, drug or alcohol abuse
  • cerclage
  • use of pessary

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Difference in cervical stiffness in women with/without preterm deliveryMeasurements between 18+0/7 and 22+0/7 weeks of pregnancy and postpartum

The biomechanical measurements and morphological data obtained at mid-pregnancy are compared between women with/without preterm delivery and are expected to significantly differ. The diagnostic power for preterm delivery of aspiration, CCI and the other factors will be determined.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (13)

University Hospital of Leuven

🇧🇪

Leuven, Belgium

Kantonsspital Aarau, Frauenklinik

🇨🇭

Aarau, Switzerland

Kantonsspital Baden, Frauenklinik

🇨🇭

Baden, Switzerland

Universitätsspital Basel, Frauenklinik

🇨🇭

Basel, Switzerland

Kantonsspital Frauenfeld, Frauenklinik

🇨🇭

Frauenfeld, Switzerland

Hôpitaux universitaires de Genève (HUG)

🇨🇭

Genève, Switzerland

Kantonsspital Luzern, Frauenklinik

🇨🇭

Luzern, Switzerland

Kantonsspital Münsterlingen

🇨🇭

Münsterlingen, Switzerland

Kantonsspital St. Gallen, Klinik für Gynäkologie und Geburtshilfe

🇨🇭

St. Gallen, Switzerland

Kantonsspital Winterthur

🇨🇭

Winterthur, Switzerland

Scroll for more (3 remaining)
University Hospital of Leuven
🇧🇪Leuven, Belgium
© Copyright 2025. All Rights Reserved by MedPath